Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer
Sentinel lymph node (SLN) biopsy is the main method in staging the axilla. There are insufficient data available regarding the accuracy of an SLN biopsy in male breast cancer. The aim of this study is to evaluate whether the combination of dye and radiotracer would improve the detection rate of SLNs...
Gespeichert in:
Veröffentlicht in: | The American surgeon 2018-12, Vol.84 (12), p.1957-1960 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1960 |
---|---|
container_issue | 12 |
container_start_page | 1957 |
container_title | The American surgeon |
container_volume | 84 |
creator | Simsek, Osman Belli, Ahmet K. Aydogan, Fatih Karatas, Adem Canbay, Emel Kepil, Nuray Selcukbiricik, Fatih Celik, Varol Uras, Cihan |
description | Sentinel lymph node (SLN) biopsy is the main method in staging the axilla. There are insufficient data available regarding the accuracy of an SLN biopsy in male breast cancer. The aim of this study is to evaluate whether the combination of dye and radiotracer would improve the detection rate of SLNs versus dye alone in male breast cancer patients. From February 2009 to January 2012, our SLN biopsy database was retrospectively reviewed to identify male breast cancer cases. Of the 890 SLN procedures contained in the database, 10 male breast cancer patients were identified. Patient age, body mass index, SLN biopsy technique, SLN identification, number of SLN excised, and pathology reports were reviewed. Mean age was 57.2 (34–85) years with a mean tumor size was 2.2 (1.0–4.0) cm. SLN detection ratios were two in four with blue dye and six in six with the combination technique. Overall, SLNs were identified in 8 of the 10 patients. SLN biopsy is applicable in male breast cancer cases. The addition of a radiotracer to the dye in SLN biopsy increases the detection rate of sentinel nodes in male breast cancer patients. |
doi_str_mv | 10.1177/000313481808401244 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2164099240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_000313481808401244</sage_id><sourcerecordid>2164099240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-ca9d8f0434d2a75d996bac720dc7889644764e70d8b775925959f335c866f7783</originalsourceid><addsrcrecordid>eNp90U9P2zAYBnBrYoJS9gV2QJa47JJhx_-PpWysUgcH4By5zpvVVWIXOzn02y9dOyYNiZNl6_e8tvUg9JmSr5QqdU0IYZRxTTXRnNCS8w9oQoUQhdElO0GTPSj24gyd57wZt1wKeorOGJFEMiEm6GUeu5UPtvcx4Cdw6-BfBsCLjB-HLSQfE-4jvt0BnrUxAPYBL2oIvW-8O4Rig_s14Mf9YYAWL3fddo3vY_0H_7Qt4JsENvd4boODdIE-NrbN8Om4TtHz929P8x_F8uFuMZ8tC8ep6AtnTa0bwhmvS6tEbYxcWadKUjultZGcK8lBkVqvlBKmFEaYhjHhtJSNUppN0ZfD3G2K45dyX3U-O2hbGyAOuSqp5MSYkpORXv1HN3FIYXzdqLRQUihuRlUelEsx5wRNtU2-s2lXUVLtC6neFjKGLo-jh1UH9WvkbwMjuD6AbH_Bv3vfGfkbFiCQkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2185765749</pqid></control><display><type>article</type><title>Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Simsek, Osman ; Belli, Ahmet K. ; Aydogan, Fatih ; Karatas, Adem ; Canbay, Emel ; Kepil, Nuray ; Selcukbiricik, Fatih ; Celik, Varol ; Uras, Cihan</creator><creatorcontrib>Simsek, Osman ; Belli, Ahmet K. ; Aydogan, Fatih ; Karatas, Adem ; Canbay, Emel ; Kepil, Nuray ; Selcukbiricik, Fatih ; Celik, Varol ; Uras, Cihan</creatorcontrib><description>Sentinel lymph node (SLN) biopsy is the main method in staging the axilla. There are insufficient data available regarding the accuracy of an SLN biopsy in male breast cancer. The aim of this study is to evaluate whether the combination of dye and radiotracer would improve the detection rate of SLNs versus dye alone in male breast cancer patients. From February 2009 to January 2012, our SLN biopsy database was retrospectively reviewed to identify male breast cancer cases. Of the 890 SLN procedures contained in the database, 10 male breast cancer patients were identified. Patient age, body mass index, SLN biopsy technique, SLN identification, number of SLN excised, and pathology reports were reviewed. Mean age was 57.2 (34–85) years with a mean tumor size was 2.2 (1.0–4.0) cm. SLN detection ratios were two in four with blue dye and six in six with the combination technique. Overall, SLNs were identified in 8 of the 10 patients. SLN biopsy is applicable in male breast cancer cases. The addition of a radiotracer to the dye in SLN biopsy increases the detection rate of sentinel nodes in male breast cancer patients.</description><identifier>ISSN: 0003-1348</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/000313481808401244</identifier><identifier>PMID: 30606355</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Adult ; Age ; Aged ; Aged, 80 and over ; Axilla ; Biopsy ; Body mass ; Body mass index ; Body size ; Breast cancer ; Breast Neoplasms, Male - pathology ; Cancer ; Coloring Agents ; Dyes ; Humans ; Identification ; Lymph nodes ; Lymph Nodes - pathology ; Lymphatic system ; Male ; Medical prognosis ; Mens health ; Metastasis ; Middle Aged ; Pathology ; Patients ; Radioactive tracers ; Radiopharmaceuticals ; Sentinel Lymph Node - pathology ; Sentinel Lymph Node Biopsy - methods ; Surgery</subject><ispartof>The American surgeon, 2018-12, Vol.84 (12), p.1957-1960</ispartof><rights>2018 Southeastern Surgical Congress</rights><rights>Copyright Southeastern Surgical Congress Dec 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-ca9d8f0434d2a75d996bac720dc7889644764e70d8b775925959f335c866f7783</citedby><cites>FETCH-LOGICAL-c415t-ca9d8f0434d2a75d996bac720dc7889644764e70d8b775925959f335c866f7783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/000313481808401244$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/000313481808401244$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30606355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simsek, Osman</creatorcontrib><creatorcontrib>Belli, Ahmet K.</creatorcontrib><creatorcontrib>Aydogan, Fatih</creatorcontrib><creatorcontrib>Karatas, Adem</creatorcontrib><creatorcontrib>Canbay, Emel</creatorcontrib><creatorcontrib>Kepil, Nuray</creatorcontrib><creatorcontrib>Selcukbiricik, Fatih</creatorcontrib><creatorcontrib>Celik, Varol</creatorcontrib><creatorcontrib>Uras, Cihan</creatorcontrib><title>Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>Sentinel lymph node (SLN) biopsy is the main method in staging the axilla. There are insufficient data available regarding the accuracy of an SLN biopsy in male breast cancer. The aim of this study is to evaluate whether the combination of dye and radiotracer would improve the detection rate of SLNs versus dye alone in male breast cancer patients. From February 2009 to January 2012, our SLN biopsy database was retrospectively reviewed to identify male breast cancer cases. Of the 890 SLN procedures contained in the database, 10 male breast cancer patients were identified. Patient age, body mass index, SLN biopsy technique, SLN identification, number of SLN excised, and pathology reports were reviewed. Mean age was 57.2 (34–85) years with a mean tumor size was 2.2 (1.0–4.0) cm. SLN detection ratios were two in four with blue dye and six in six with the combination technique. Overall, SLNs were identified in 8 of the 10 patients. SLN biopsy is applicable in male breast cancer cases. The addition of a radiotracer to the dye in SLN biopsy increases the detection rate of sentinel nodes in male breast cancer patients.</description><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Axilla</subject><subject>Biopsy</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>Breast cancer</subject><subject>Breast Neoplasms, Male - pathology</subject><subject>Cancer</subject><subject>Coloring Agents</subject><subject>Dyes</subject><subject>Humans</subject><subject>Identification</subject><subject>Lymph nodes</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Mens health</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Pathology</subject><subject>Patients</subject><subject>Radioactive tracers</subject><subject>Radiopharmaceuticals</subject><subject>Sentinel Lymph Node - pathology</subject><subject>Sentinel Lymph Node Biopsy - methods</subject><subject>Surgery</subject><issn>0003-1348</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp90U9P2zAYBnBrYoJS9gV2QJa47JJhx_-PpWysUgcH4By5zpvVVWIXOzn02y9dOyYNiZNl6_e8tvUg9JmSr5QqdU0IYZRxTTXRnNCS8w9oQoUQhdElO0GTPSj24gyd57wZt1wKeorOGJFEMiEm6GUeu5UPtvcx4Cdw6-BfBsCLjB-HLSQfE-4jvt0BnrUxAPYBL2oIvW-8O4Rig_s14Mf9YYAWL3fddo3vY_0H_7Qt4JsENvd4boODdIE-NrbN8Om4TtHz929P8x_F8uFuMZ8tC8ep6AtnTa0bwhmvS6tEbYxcWadKUjultZGcK8lBkVqvlBKmFEaYhjHhtJSNUppN0ZfD3G2K45dyX3U-O2hbGyAOuSqp5MSYkpORXv1HN3FIYXzdqLRQUihuRlUelEsx5wRNtU2-s2lXUVLtC6neFjKGLo-jh1UH9WvkbwMjuD6AbH_Bv3vfGfkbFiCQkQ</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Simsek, Osman</creator><creator>Belli, Ahmet K.</creator><creator>Aydogan, Fatih</creator><creator>Karatas, Adem</creator><creator>Canbay, Emel</creator><creator>Kepil, Nuray</creator><creator>Selcukbiricik, Fatih</creator><creator>Celik, Varol</creator><creator>Uras, Cihan</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201812</creationdate><title>Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer</title><author>Simsek, Osman ; Belli, Ahmet K. ; Aydogan, Fatih ; Karatas, Adem ; Canbay, Emel ; Kepil, Nuray ; Selcukbiricik, Fatih ; Celik, Varol ; Uras, Cihan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-ca9d8f0434d2a75d996bac720dc7889644764e70d8b775925959f335c866f7783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Axilla</topic><topic>Biopsy</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>Breast cancer</topic><topic>Breast Neoplasms, Male - pathology</topic><topic>Cancer</topic><topic>Coloring Agents</topic><topic>Dyes</topic><topic>Humans</topic><topic>Identification</topic><topic>Lymph nodes</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Mens health</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Pathology</topic><topic>Patients</topic><topic>Radioactive tracers</topic><topic>Radiopharmaceuticals</topic><topic>Sentinel Lymph Node - pathology</topic><topic>Sentinel Lymph Node Biopsy - methods</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simsek, Osman</creatorcontrib><creatorcontrib>Belli, Ahmet K.</creatorcontrib><creatorcontrib>Aydogan, Fatih</creatorcontrib><creatorcontrib>Karatas, Adem</creatorcontrib><creatorcontrib>Canbay, Emel</creatorcontrib><creatorcontrib>Kepil, Nuray</creatorcontrib><creatorcontrib>Selcukbiricik, Fatih</creatorcontrib><creatorcontrib>Celik, Varol</creatorcontrib><creatorcontrib>Uras, Cihan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simsek, Osman</au><au>Belli, Ahmet K.</au><au>Aydogan, Fatih</au><au>Karatas, Adem</au><au>Canbay, Emel</au><au>Kepil, Nuray</au><au>Selcukbiricik, Fatih</au><au>Celik, Varol</au><au>Uras, Cihan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2018-12</date><risdate>2018</risdate><volume>84</volume><issue>12</issue><spage>1957</spage><epage>1960</epage><pages>1957-1960</pages><issn>0003-1348</issn><eissn>1555-9823</eissn><abstract>Sentinel lymph node (SLN) biopsy is the main method in staging the axilla. There are insufficient data available regarding the accuracy of an SLN biopsy in male breast cancer. The aim of this study is to evaluate whether the combination of dye and radiotracer would improve the detection rate of SLNs versus dye alone in male breast cancer patients. From February 2009 to January 2012, our SLN biopsy database was retrospectively reviewed to identify male breast cancer cases. Of the 890 SLN procedures contained in the database, 10 male breast cancer patients were identified. Patient age, body mass index, SLN biopsy technique, SLN identification, number of SLN excised, and pathology reports were reviewed. Mean age was 57.2 (34–85) years with a mean tumor size was 2.2 (1.0–4.0) cm. SLN detection ratios were two in four with blue dye and six in six with the combination technique. Overall, SLNs were identified in 8 of the 10 patients. SLN biopsy is applicable in male breast cancer cases. The addition of a radiotracer to the dye in SLN biopsy increases the detection rate of sentinel nodes in male breast cancer patients.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>30606355</pmid><doi>10.1177/000313481808401244</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-1348 |
ispartof | The American surgeon, 2018-12, Vol.84 (12), p.1957-1960 |
issn | 0003-1348 1555-9823 |
language | eng |
recordid | cdi_proquest_miscellaneous_2164099240 |
source | MEDLINE; SAGE Complete |
subjects | Adult Age Aged Aged, 80 and over Axilla Biopsy Body mass Body mass index Body size Breast cancer Breast Neoplasms, Male - pathology Cancer Coloring Agents Dyes Humans Identification Lymph nodes Lymph Nodes - pathology Lymphatic system Male Medical prognosis Mens health Metastasis Middle Aged Pathology Patients Radioactive tracers Radiopharmaceuticals Sentinel Lymph Node - pathology Sentinel Lymph Node Biopsy - methods Surgery |
title | Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A27%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20Technique%20Is%20Superior%20to%20Dye%20Alone%20in%20Identification%20of%20the%20Sentinel%20Lymph%20Node%20in%20Male%20Breast%20Cancer&rft.jtitle=The%20American%20surgeon&rft.au=Simsek,%20Osman&rft.date=2018-12&rft.volume=84&rft.issue=12&rft.spage=1957&rft.epage=1960&rft.pages=1957-1960&rft.issn=0003-1348&rft.eissn=1555-9823&rft_id=info:doi/10.1177/000313481808401244&rft_dat=%3Cproquest_cross%3E2164099240%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2185765749&rft_id=info:pmid/30606355&rft_sage_id=10.1177_000313481808401244&rfr_iscdi=true |